Your session is about to expire
← Back to Search
CereGate Therapy for Freezing of Gait in PD
Study Summary
This trial is testing if a new therapy can help people with Parkinson's disease who have freezing of gait.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had deep brain stimulation (DBS) treatment and it has improved your motor skills, as shown in documentation.I am willing and able to follow the study's schedule and procedures.I understand the study and can give my consent.I am in the most advanced stage of Parkinson's disease and need help moving around.I have a history of seizures that happen without warning.I have a Boston Scientific Gevia STN-DBS system implanted.I am a woman who could be pregnant, am pregnant, or am breastfeeding and not using strong birth control.My DBS settings have been unchanged for less than 28 days before starting CG.I am either younger than 21 or older than 75.I have a condition that affects my ability to walk.My heart rhythm irregularity is less than 8% before starting CG therapy.I am taking medication for Parkinson's disease as prescribed by a specialist.I experience uncontrollable movements.I have had thoughts of harming myself or attempted suicide.I did not feel distinct sensations on both sides during the STN stimulation test.My doctor expects I have less than a year to live due to my illness.I am on the best dose of Parkinson's medication as decided by my neurologist.
- Group 1: PD Patients treated with CereGate Software
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the overall participant count for this investigation?
"The clinical trial necessitates the enrollment of 41 suitable candidates. Participants may register at Kaiser Permanente, KPNC Comprehensive Movement Disorders Program in Redwood City, California or Cedars Sinai Neurology in Los Angeles, Colorado."
Is the age cutoff for this trial restrictive to those over 50?
"This study requires that all participants be aged between 21 and 75. Concerning younger or older individuals, there are 27 trials for minors and 496 studies specifically recruiting seniors."
Are there any US-based healthcare institutions that are currently trialing this?
"The study is being run by 4 key organisations: Kaiser Permanente, KPNC Comprehensive Movement Disorders Program in Redwood City, Cedars Sinai Neurology in Los Angeles and University of Colorado Anschutz Medical Campus in Aurora. Additionally, there are other sites carrying out the trial at different locations."
Might I have the opportunity to join this clinical experiment?
"This medical research is aiming to acquire 41 participants aged 21-75 with a current diagnosis of Parkinson's disease. Other prerequisites for participation include; evidence of successful Boston Scientific Gevia STN-DBS implantation, therapeutic use of Carbidopa/Levodopa and dopamine agonists monitored by a movement disorders neurologist, plus improved motor signs (UPDRSIII) from Deep Brain Stimulation optimization."
Are there currently any opportunities to join this trial?
"Indeed, the clinical trial is still open to participants. The first posting was on 18 April 2022 and its most recent update took place on 15 November 2022, as per information found on clinicaltrials.gov"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- University of Washington: < 48 hours
Share this study with friends
Copy Link
Messenger